Please login to the form below

Not currently logged in
Email:
Password:

bluebird bio lodges counterclaim against Spark Therapeutics

Spark previously accused bluebird of misusing trademarks relating to the word ‘spark’ in marketing/educational materials

bluebird bio has launched a counterclaim against Spark Therapeutics after the latter initiated a dispute a few months ago, according to Boston Business Journal.

Earlier this year, Spark filed a lawsuit against bluebird alleging that the company misused trademarks relating to the word ‘spark’ in marketing/educational materials.

Specifically, the complaint accuses bluebird bio of infringing on and diluting Spark Therapeutics’ trademark, relating to bluebird bio’s educational and informational campaign about sickle cell disease ‘Be the Spark’ which was shared on social media sites and other locations.

In response, bluebird bio’s counterclaim says Spark’s lawsuit is a ‘misguided exercise’, with the Philadelphia Business Journal reporting that the counterclaim argues that the word ‘spark’ is free to use under the doctrine of fair use.

In addition, bluebird bio has argued that it did not wilfully infringe on Spark Therapeutics, using the word ‘spark’ solely to describe its ‘goods and services’.

bluebird bio is developing its gene therapy LentiGlobin for sickle cell disease, which currently has an orphan drug designation as well as fast track and rare paediatric disease designations from the US Food and Drug Administration (FDA).

Spark Therapeutics was acquired by Roche for $4.3bn in February 2019, enabling the Swiss pharma giant to gain a presence in the gene therapy area.

The biotech company became the first company to receive approval for a gene therapy in the US for its rare inherited retinal disease treatment Luxturna (voretigene neparvovec).

Spark Therapeutics is also developing a gene therapy for the potential treatment of haemophilia, which has gained positive results in previous clinical studies.

Article by
Lucy Parsons

8th July 2021

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...